Gene · 316
Papers2,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level. | Pharmacogenomics | 2024 | 39347581 | PubTator, text mining | PubMed |
| The Potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics. | J Immunol Res | 2024 | 39156005 | PubTator, text mining | PubMed |
| Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol. | Rheumatology (Oxford) | 2024 | 39137147 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis and experimental validation to understand tryptophan metabolism-related genes in hepatocellular carcinoma. | J Cancer | 2024 | 39132147 | PubTator, text mining | PubMed |
| A Review: Development of a Synthetic Lactoferrin Biological System. | Biodes Res | 2024 | 39108279 | PubTator, text mining | PubMed |
| Nicotine inhalation and metabolism triggers AOX-mediated superoxide generation with oxidative lung injury. | J Biol Chem | 2024 | 39098528 | PubTator, text mining | PubMed |
| Identification of biomarkers related to tryptophan metabolism in osteoarthritis. | Biochem Biophys Rep | 2024 | 39040542 | PubTator, text mining | PubMed |
| Role of AOX1 on RXR signaling regulates osteoblastogenesis in hPDLMSCs. | Sci Rep | 2024 | 39034354 | PubTator, text mining | PubMed |
| The Drug-Drug Interaction between Erlotinib and OSI-930 Is Mediated through Aldehyde Oxidase Inhibition. | Drug Metab Dispos | 2024 | 38889967 | PubTator, text mining | PubMed |
| Investigating the potential of 6-substituted 3-formyl chromone derivatives as anti-diabetic agents using in silico methods. | Sci Rep | 2024 | 38851807 | PubTator, text mining | PubMed |
| [Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia]. | Yakugaku Zasshi | 2024 | 38825475 | PubTator, text mining | PubMed |
| Comprehensive analysis of abnormal methylation modification differential expression mRNAs between low-grade and high-grade intervertebral disc degeneration and its correlation with immune cells. | Ann Med | 2024 | 38819022 | PubTator, text mining | PubMed |
| Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism. | Mol Pharm | 2024 | 38717252 | PubTator, text mining | PubMed |
| Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: in vitro and pharmacoepidemiological approaches. | Expert Opin Drug Metab Toxicol | 2024 | 38706380 | PubTator, text mining | PubMed |
| Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity. | Chem Res Toxicol | 2024 | 38619497 | PubTator, text mining | PubMed |
| Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes. | Drug Metab Dispos | 2024 | 38565303 | PubTator, text mining | PubMed |
| Novel Multiplexed High Throughput Screening of Selective Inhibitors for Drug-Metabolizing Enzymes Using Human Hepatocytes. | AAPS J | 2024 | 38546903 | PubTator, text mining | PubMed |
| Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes. | Arch Toxicol | 2024 | 38520539 | PubTator, text mining | PubMed |
| Correction to "Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs". | Drug Metab Dispos | 2024 | 38479790 | PubTator, text mining | PubMed |
| Discovery of TRPA1 Antagonist GDC-6599: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory Disease. | J Med Chem | 2024 | 38431835 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/316/papers?page=5